Clinical-stage dermatology company Provectus Biopharmaceuticals, which works in the fields of oncology and dermatology, has been granted allowance of its patent application from both the European Patent Office and the Japanese Patent Office for part of the development process of its lead product to treat melanoma. The patents cover the synthetic process for the production of the active … Continue reading Provectus’ Synthesis Patent Granted by Europe and Japan